Interview: Brian Lewis – President & CEO, MEDEC, Canada
Brian Lewis, president and CEO of MEDEC, speaks towards the importance of building a strong medical device…
MEDEC, Canada
Last updated: 13.02.2014
Established in 1973, MEDEC is the national association representing Canada’s innovative medical technology (medtech) industry. Representing approximately 150 medtech companies (ranging from Canadian-owned to multinationals), MEDEC works closely with the federal and provincial-territorial governments, health professionals, patients and other stakeholders to deliver a patient-centred, safe, accessible, innovative and sustainable, universal healthcare system supported by the use of medical technology.
MEDEC is governed by a Board of Directors representing the diverse perspectives and experiences of its members from across the country.
Our Vision
Serving as an essential partner in providing better health and more sustainable healthcare for Canadians.
Our Mission
MEDEC speaks with one voice for Canada’s medical technology companies in advocating for a responsive, safe and sustainable healthcare system that is enabled by the use of Medical Technology. For more than 40 years, MEDEC has delivered essential programs and services to its member companies (members), including:
• Serving as a trusted thought leader on current issues affecting the medtech industry, the healthcare system and international trade
• Providing access and strategic opportunities for collaboration with government and other health partners
• Delivering timely communications and advocacy tools on key issues that matter to members
• Hosting timely educational sessions to keep members current on industry trends, legislative and policy initiatives at the federal and provincial-territorial level
• Hosting practical forums to accelerate knowledge transfer and the exchange of best practices
• Promoting broad awareness about medical technology’s contributions to patient care, the healthcare system and to the broader economy.
Interviews
Interview: Brian Lewis, CEO, MEDEC, Canada
MEDEC is the national association created by and for the Canadian medical technology industry. Brian Lewis,…
Related
Canada / Concrete Steps Toward National Pharmacare
Writing in the September edition of DIA’s Global Forum magazine, Dr Judith Glennie examines the specific…
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Canada / The Evolution of Medical Cannabis Legislation
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
Canada / Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt…
Pricing / Drugmakers Push Back Against Canada's New Regulations
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory…
Alzheimer's / Canadian-Led Innovation Post-Aducanumab
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
Canada / Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the…
Opinion / A New Approach to Rare Diseases in Canada
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to…
Pharma Faces / Marina Vasiliou, Biogen Canada
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied…
Canada / Collective Impact in the Health Charity Sector
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to…
Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial…
